Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

MTOR-S2215Y phosphorylates RPS6KB1. 2 / 2

| 2

➶

reach

"We next examined whether rapamycin, an mTOR inhibitor, inhibits the enhanced phosphorylation of S6K1 by mTOR S2215Y."

20190810

➶

reach

"MTOR S2215Y also enhanced the phosphorylation of S6K1 but, in the presence of rapamycin, S6K1 phosphorylation was completely abolished."

20190810

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...